Dr. Adam Shapiro, Montréal Children’s Hospital, Montréal, QC

This presentation will provide summary information on the recent American Thoracic Society clinical practice guidelines for diagnosis of Primary Ciliary Dyskinesia (PCD), as well as review of the PCD Foundation consensus statement document on recommended therapies for patients with PCD.

Learning Objectives

At the end of this presentation, attendees will be able to:

  • recognize the clinical phenotype encountered in classic PCD and when to investigate for this rare disease;
  • understand the limitations of clinical PCD testing and which tests are currently recommended in North America; and
  • become familiar with the currently recommended therapies for acute and chronic management of PCD.